CH498819A - Verfahren zur Herstellung von Steroidketonen mit 17- oder 17a-Halogenalkinylgruppen - Google Patents

Verfahren zur Herstellung von Steroidketonen mit 17- oder 17a-Halogenalkinylgruppen

Info

Publication number
CH498819A
CH498819A CH1052964A CH1052964A CH498819A CH 498819 A CH498819 A CH 498819A CH 1052964 A CH1052964 A CH 1052964A CH 1052964 A CH1052964 A CH 1052964A CH 498819 A CH498819 A CH 498819A
Authority
CH
Switzerland
Prior art keywords
group
chloroethinyl
ethyl
hydrogen
ether
Prior art date
Application number
CH1052964A
Other languages
German (de)
English (en)
Inventor
Alan Dr Hughes Gordon
Herchel Dr Smith
Original Assignee
Smith Herchel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK448162AA external-priority patent/DK113641B/da
Priority claimed from GB3206463A external-priority patent/GB1100441A/en
Application filed by Smith Herchel filed Critical Smith Herchel
Priority to CH1742168A priority Critical patent/CH498821A/de
Priority to CH381370A priority patent/CH499510A/de
Priority to CH1387870A priority patent/CH507225A/de
Priority to CH1742068A priority patent/CH498820A/de
Publication of CH498819A publication Critical patent/CH498819A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pressure-Spray And Ultrasonic-Wave- Spray Burners (AREA)
CH1052964A 1961-10-19 1964-08-12 Verfahren zur Herstellung von Steroidketonen mit 17- oder 17a-Halogenalkinylgruppen CH498819A (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CH1742168A CH498821A (de) 1962-10-17 1964-08-12 Verfahren zur Herstellung von Steroidketonderivaten mit 17- und 17a-Halogenalkinylgruppen
CH381370A CH499510A (de) 1962-10-17 1964-08-12 Verfahren zur Herstellung von Steroidketonderivaten mit 17-oder 17a-Halogenalkinylgruppen
CH1387870A CH507225A (de) 1962-10-17 1964-08-12 Verfahren zur Herstellung von Steroidketonen mit 17- oder 17a-Halogenalkinylgruppen
CH1742068A CH498820A (de) 1961-10-19 1964-08-12 Verfahren zur Herstellung von Steroidketonderivaten mit 17- oder 17a-Halogenalkinylgruppen

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK448162AA DK113641B (da) 1961-10-19 1962-10-17 Fremgangsmåde til fremstilling af steroidketoner.
GB3206463A GB1100441A (en) 1963-08-14 1963-08-14 13-alkyl 17-halogenoalkynyl-steroid 3-ketones and their derivatives
DK400464A DK134161B (da) 1962-10-17 1964-08-13 Analogifremgangsmåde til fremstilling af steroidketoner.

Publications (1)

Publication Number Publication Date
CH498819A true CH498819A (de) 1970-11-15

Family

ID=27221920

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1052964A CH498819A (de) 1961-10-19 1964-08-12 Verfahren zur Herstellung von Steroidketonen mit 17- oder 17a-Halogenalkinylgruppen

Country Status (14)

Country Link
JP (1) JPS4837029B1 (xx)
AT (3) AT301045B (xx)
BE (1) BE651797A (xx)
BR (1) BR6461643D0 (xx)
CH (1) CH498819A (xx)
DE (4) DE1618872C3 (xx)
DK (3) DK134161B (xx)
FR (2) FR1566154A (xx)
GB (2) GB1100443A (xx)
IL (1) IL21826A (xx)
IN (2) IN95058B (xx)
NL (2) NL139307B (xx)
NO (3) NO126016B (xx)
SE (5) SE331470B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2913381A1 (de) * 1979-03-30 1980-10-16 Schering Ag 11-methylensteroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
JPS57106714U (xx) * 1980-12-23 1982-07-01
DE3214689A1 (de) * 1982-04-16 1983-10-27 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-chlor-steroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
WO2012110947A1 (en) * 2011-02-17 2012-08-23 Lupin Limited An improved process for preparation of levonorgestrel

Also Published As

Publication number Publication date
DE1618872B2 (de) 1974-03-07
NO126016B (xx) 1972-12-11
IN137555B (xx) 1975-08-16
SE350256B (xx) 1972-10-23
DE1468988B1 (de) 1971-11-25
FR4915M (xx) 1967-03-20
IN95058B (xx) 1975-08-16
DK127598B (da) 1973-12-03
NO127193B (xx) 1973-05-21
NL7308508A (xx) 1973-09-25
SE335119B (xx) 1971-05-17
DK127475B (da) 1973-11-12
BE651797A (xx)
AT301039B (de) 1972-08-25
JPS4837029B1 (xx) 1973-11-08
GB1100443A (en) 1968-01-24
DE1618871C3 (de) 1974-02-21
SE335120B (xx) 1971-05-17
DK134161C (xx) 1977-02-21
DK134161B (da) 1976-09-20
AT269376B (de) 1969-03-10
DE1793641C2 (de) 1973-12-20
GB1100444A (en) 1968-01-24
DE1618871A1 (de) 1972-08-10
FR1566154A (xx) 1969-05-09
DE1618871B2 (de) 1973-07-26
DE1618872C3 (de) 1974-10-24
BR6461643D0 (pt) 1973-08-09
DE1793641B1 (de) 1973-05-24
NL6409391A (xx) 1965-02-15
NO129905B (xx) 1974-06-10
AT301045B (de) 1972-08-25
SE334879B (xx) 1971-05-10
DE1618872A1 (de) 1972-06-15
SE331470B (xx) 1971-01-04
IL21826A (en) 1968-12-26
NL139307B (nl) 1973-07-16

Similar Documents

Publication Publication Date Title
CH498819A (de) Verfahren zur Herstellung von Steroidketonen mit 17- oder 17a-Halogenalkinylgruppen
DE1793633C3 (de) Verfahren zur Herstellung von Gona 4(5),9(10)dien3 onen Ausscheidung aus 1468642
CH494216A (de) Verfahren zur Herstellung von in 3-Stellung einer verätherte Hydroxygruppe tragenden 6-Aminomethyl- 3,5-steroiden
DE1468988C (de) nalpha-Chloräthinyl-lSbeta-äthyl-4-oder-5( 10)- gonen-3 -ketone.'
DE1012299B (de) Verfahren zur Herstellung eines Pregnan-3-ol-20-on-3-aethers oder -esters
DE1793687C3 (de) Verfahren zur Herstellung von Steroidverbindungen. Ausscheidung aus: 1493108
DE1443123C (de) Verfahren zur Herstellung von 13 Alkyl gona 1,3,5(10) tnenen
DE1593444C3 (de) In 17-Stellung substituierte 3-Methoxy-I1 beta-methyl-östra-1,3,5(10)-triene und Verfahren zu ihrer Herstellung
DE1264441B (de) Verfahren zur Herstellung von 17alpha-AEthinyl-delta 5(10-19-nor-androsten-17beta-ol-3-on und 17alpha-AEthynil-19-nor-testosteron sowie dessen Estern
AT270884B (de) Verfahren zur Herstellung von neuen 4,6-Pregnadienderivaten
DE1230795B (de) Verfahren zur Herstellung von Androstano [2, 3-c]furazan-derivaten
DE1493108C (de) Steroidverbindungen
DE1793630C3 (de) 17 alpha-Alkanoyloxy-9 alpha-fluor-11 beta-hydroxy-16-methyl-pregna-1 ,4dien-3,20-dione und Verfahren zu deren Herstellung
DE1668665C (de) Verfahren zur Herstellung von 13-Alky 1-gona-1,3,5( 10)-trienen. Ausscheidung aus: 1443123
DE1568688C3 (de) Verfahren zur Herstellung von 3-Oxo-4,6-dehydro-19-nor-steroiden, sowie 17 beta-Hydroxy-8 alpha, 10 alpha-östra-4,6-dien-3-on
DE2003653B2 (de) Verfahren zur Herstellung von Pregnan-20-on-3beta, 5beta, 14beta, 21-tetrol bzw. dessen 3,21-di-tetrahydropyranyläther sowie die entsprechenden Zwischenprodukte
DE1443123A1 (de) Verfahren zur Herstellung von 13-Alkyl-gona-1,3,5(10)-trienen
DE1568766B2 (de) Verfahren zur Herstellung von Steroiden der Pregnanreihe sowie 19-Nor-pregna-1,3,5 (10) -trlen -3,20 alpha-diol und dessen 3- nieder-Alkyläther als Zwischenprodukte
DE1593444B2 (de) In 17-stellung substituierte 3-methoxy- 11 beta-methyl-oestra-1,3,5(10)-triene und verfahren zu ihrer herstellung
CH561229A5 (en) Substd. tetra-enes and trienes - oestrogenic and antilipaemic
DE1211637B (de) Verfahren zur gegebenenfalls voruebergehenden, selektiven 3-Ketalisierung von weiteren Oxogruppen enthaltenden delta 5(10)-3-Oxo-19-nor-steroiden
CH498820A (de) Verfahren zur Herstellung von Steroidketonderivaten mit 17- oder 17a-Halogenalkinylgruppen
DE1008286B (de) Verfahren zur Herstellung von in 8(9)-Stellung gesaettigten 11-Oxy- und bzw. oder 11-Ketosteroiden
DE1793630B2 (de) 17 alpha-Alkanoyloxy-9 alpha-fluor-11 beta-hydroxy-16-methyl-pregna-1,4dien-3,20-dione und Verfahren zu deren Herstellung
CH421954A (de) Verfahren zur Herstellung von 7a-Methylsteroiden

Legal Events

Date Code Title Description
PL Patent ceased